Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Debt / NOTE 1.000% 9/1
-
Market price (% of par)
-
237.25%
-
Total 13F principal
-
$228,106,500
-
Principal change
-
$0
-
Total reported market value
-
$541,079,700
-
Number of holders
-
23
Institutional Holders of UNITED THERAPEUTICS CORP DEL - NOTE 1.000% 9/1 as of Q4 2013
As of 31 Dec 2013,
UNITED THERAPEUTICS CORP DEL - NOTE 1.000% 9/1 was held by
23 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$228,106,500
in principal (par value) of the bond.
The largest 10 bondholders included
Whitebox Advisors LLC, CAMDEN ASSET MANAGEMENT L P /CA, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Castle Creek Arbitrage, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, BASSO CAPITAL MANAGEMENT L.P., Citadel Advisors LLC, WOLVERINE ASSET MANAGEMENT LLC, UBS OCONNOR LLC, and BANK OF AMERICA CORP /DE/.
This page lists
23
institutional bondholders reporting positions
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.